Browse by Medical Category
Accepting New Patients
Go To Programs
MassGeneral Hospital for Children
Go To Specialties
Dr. Timothy Wilens is Associate Professor of Psychiatry at Harvard Medical School in Boston, Massachusetts. In addition, he is Director of Substance Abuse Services in the Clinical and Research Program in Pediatric Psychopharmacology at Massachusetts General Hospital. Dr. Wilens earned his BS in literature, science, and arts at the University of Michigan Honors College and his MD at the University of Michigan Medical School in Ann Arbor. His residency in child, adolescent, adult, and addiction psychiatry was completed at Massachusetts General Hospital under the auspices of Harvard Medical School in Boston.
Dr. Wilens' research interests include the relationship among attention deficit/hyperactivity disorder (ADHD), bipolar disorder, and substance abuse, and the pharmacotherapy of ADHD and juvenile bipolar disorder across the lifespan. His peer-reviewed articles concerning these and related topics number more than 200, and are published in prestigious journals such as the American Journal of Psychiatry, Archives of General Psychiatry, and Pediatrics. Dr. Wilens has also published more than 60 book chapters, and 300 abstracts and presentations for national and international scientific meetings.
Dr. Wilens is a Distinguished Fellow of the American Psychiatric Association and the American Academy of Child and Adolescent Psychiatry, serves as a scientific reviewer for 22 journals, and is active in a number of other local and national professional societies. Dr. Wilens is named consistently among "The Best of Boston" in Child/Adult Psychiatry and "The Best Doctors in America."
View my most recent publications at PubMed
The MGH Department of Psychiatry recently announced that Timothy E. Wilens, MD, has been named the new chief of the Division of Child and Adolescent Psychiatry, effective Aug. 1.
Dr. Timothy Wilens, director of the Center for Addiction Medicine and Substance Abuse Services in Pediatric Psychopharmacology at MassGeneral for Children, discusses Molly, the new club drug that's been associated with overdoses in New England.
The results of two long-term studies conducted by Massachusetts General Hospital researchers have shown that attention-deficit hyperactivity disorder (ADHD) significantly increases the risk of cigarette smoking and substance abuse in both boys and girls.
An analysis of more than 10 years of data confirms that ADHD alone significantly increases the risk of future cigarette smoking and substance abuse in both boys and girls.
Back to Top